Literature DB >> 14516783

Regulation of human apolipoprotein B gene expression at multiple levels.

Ai-Bing Wang1, De-Pei Liu, Chih-Chuan Liang.   

Abstract

Apolipoprotein B is a large, amphipathic protein that plays a central role in lipoprotein metabolism. Because its overproduction and deficiency leads to metabolic and pathologic disorders, much effort has been paid to investigate the mechanisms of how its homeostasis is achieved. Earlier and recent studies have showed that apoB gene locus might reside in different chromatin domains in the hepatic and intestinal cells, and two sets of very distinct regulatory elements operate to control its transcription. Posttranscriptional modification of apoB mRNA is performed by a multicomponent enzyme complex, several possible pathways regulate the editing efficiency. Understanding of the mechanism responsible for apoB mRNA editing will provide the basis for C-to-U editing in gene therapy. In addition to apoB mRNA abundance and stability, its translation can be also regulated at the steps of elongation. The translocation of apoB into the ER is an important and complicated process that is less understood. Successful transport and correct folding of apoB may lead to its final secretion, otherwise subject to intracellular degradation, which is accomplished by proteasomal and nonproteasomal pathways at multiple levels and may differ among cell types.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14516783     DOI: 10.1016/s0014-4827(03)00313-6

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  Hepatic very-low-density lipoprotein and apolipoprotein B production are increased following in vivo induction of betaine-homocysteine S-methyltransferase.

Authors:  Janet D Sparks; Heidi L Collins; Doru V Chirieac; Joanne Cianci; Jenny Jokinen; Mark P Sowden; Chad A Galloway; Charles E Sparks
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

2.  Genetic polymorphism of APOB is associated with diabetes mellitus in sickle cell disease.

Authors:  Xu Zhang; Wei Zhang; Santosh L Saraf; Mehdi Nouraie; Jin Han; Michel Gowhari; Johara Hassan; Galina Miasnikova; Adelina Sergueeva; Sergei Nekhai; Rick Kittles; Roberto F Machado; Joe G N Garcia; Mark T Gladwin; Martin H Steinberg; Paola Sebastiani; Donald A McClain; Victor R Gordeuk
Journal:  Hum Genet       Date:  2015-05-30       Impact factor: 4.132

3.  Metabolism of Triglyceride-Rich Lipoproteins.

Authors:  Jan Borén; Marja-Riitta Taskinen
Journal:  Handb Exp Pharmacol       Date:  2022

Review 4.  Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia.

Authors:  Jan Borén; Marja-Riitta Taskinen; Elias Björnson; Chris J Packard
Journal:  Nat Rev Cardiol       Date:  2022-03-22       Impact factor: 49.421

5.  A strategy for developing a hammerhead ribozyme for selective RNA cleavage depending on substitutional RNA editing.

Authors:  Masatora Fukuda; Kei Kurihara; Yasuyoshi Tanaka; Masanobu Deshimaru
Journal:  RNA       Date:  2012-07-13       Impact factor: 4.942

6.  Decreased expression of Intestinal I- and L-FABP levels in rare human genetic lipid malabsorption syndromes.

Authors:  S Guilmeau; I Niot; J P Laigneau; H Devaud; V Petit; N Brousse; R Bouvier; L Ferkdadji; C Besmond; L P Aggerbeck; A Bado; M E Samson-Bouma
Journal:  Histochem Cell Biol       Date:  2007-06-29       Impact factor: 4.304

7.  Cellular Gene Expression during Hepatitis C Virus Replication as Revealed by Ribosome Profiling.

Authors:  Gesche K Gerresheim; Jochen Bathke; Audrey M Michel; Dmitri E Andreev; Lyudmila A Shalamova; Oliver Rossbach; Pan Hu; Dieter Glebe; Markus Fricke; Manja Marz; Alexander Goesmann; Stephen J Kiniry; Pavel V Baranov; Ivan N Shatsky; Michael Niepmann
Journal:  Int J Mol Sci       Date:  2019-03-15       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.